Post-COVID syndrome: an insight on its pathogenesis
Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …
Single-cell immunology of SARS-CoV-2 infection
Gaining a better understanding of the immune cell subsets and molecular factors associated
with protective or pathological immunity against severe acute respiratory syndrome …
with protective or pathological immunity against severe acute respiratory syndrome …
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
Remdesivir is an antiviral approved for COVID-19 treatment, but its wider use is limited by
intravenous delivery. An orally bioavailable remdesivir analog may boost therapeutic benefit …
intravenous delivery. An orally bioavailable remdesivir analog may boost therapeutic benefit …
[HTML][HTML] SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: a systematic review
S Shenoy - World Journal of Critical Care Medicine, 2021 - ncbi.nlm.nih.gov
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections
is diagnosed via real time reverse transcriptase polymerase chain reaction (RT-PCR) and …
is diagnosed via real time reverse transcriptase polymerase chain reaction (RT-PCR) and …
Possible use of phytochemicals for recovery from COVID-19-induced anosmia and ageusia
The year 2020 became the year of the outbreak of coronavirus, SARS-CoV-2, which
escalated into a worldwide pandemic and continued into 2021. One of the unique symptoms …
escalated into a worldwide pandemic and continued into 2021. One of the unique symptoms …
SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: a retrospective cross-sectional cohort study
S Euser, S Aronson, I Manders… - International journal …, 2021 - academic.oup.com
Abstract Background Describing the SARS-CoV-2 viral-load distribution in different patient
groups and age categories. Methods All results from first nasopharyngeal (NP) and …
groups and age categories. Methods All results from first nasopharyngeal (NP) and …
[HTML][HTML] A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel
E Goldberg, HB Zvi, L Sheena, S Sofer, I Krause… - Clinical Microbiology …, 2021 - Elsevier
Objectives The effectiveness of remdesivir, a Food and Drug Administration-approved drug
for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been repeatedly …
for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been repeatedly …
Mechanisms contributing to adverse outcomes of COVID-19 in obesity
M Sudhakar, SB Winfred, G Meiyazhagan… - Molecular and cellular …, 2022 - Springer
A growing amount of epidemiological data from multiple countries indicate an increased
prevalence of obesity, more importantly central obesity, among hospitalized subjects with …
prevalence of obesity, more importantly central obesity, among hospitalized subjects with …
Association between SARS-CoV-2 cycle threshold values and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
VP Shah, WH Farah, JC Hill, LC Hassett… - Open forum …, 2021 - academic.oup.com
Cycle threshold (CT) values are correlated with the amount of viral nucleic acid in a sample
and may be obtained from some qualitative real-time polymerase chain reaction tests used …
and may be obtained from some qualitative real-time polymerase chain reaction tests used …
Household transmission of severe acute respiratory syndrome coronavirus 2 in the United States: living density, viral load, and disproportionate impact on …
Background Households are hot spots for severe acute respiratory syndrome coronavirus 2
transmission. Methods This prospective study enrolled 100 coronavirus disease 2019 …
transmission. Methods This prospective study enrolled 100 coronavirus disease 2019 …